NCT05339334View on ClinicalTrials.gov

A Study to Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants.

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 10, 2022

Primary Completion Date

April 21, 2022

Study Completion Date

April 21, 2022

Conditions
Healthy Participants
Interventions
DRUG

PF-07321332/ritonavir

PF-07321332/ritonavir will be given by mouth two times a day for 10 days

Trial Locations (1)

201107

Huashan Hospital,Fudan University, Shanghai

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT05339334 - A Study to Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants. | Biotech Hunter | Biotech Hunter